gabexate has been researched along with Hemolysis in 5 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumura, T | 1 |
| Aoyama, Y | 1 |
| Ichihara, H | 1 |
| Koh, S | 1 |
| Mugitani, A | 1 |
| Hayakawa, H | 1 |
| Yukioka, K | 1 |
| Kinoshita, D | 1 |
| Nakagawa, M | 1 |
| Yamazaki, N | 1 |
| Fujita, H | 1 |
| Sakuma, R | 1 |
| Fujimoto, S | 1 |
| Hazama, Y | 1 |
| Ohtake, C | 1 |
| Moriyama, A | 1 |
| Kuhara, K | 1 |
| Nishimura, S | 1 |
| Nakamura, K | 1 |
| Johmura, A | 1 |
| Oda, M | 1 |
| Ino, Y | 2 |
| Uchiyama, H | 1 |
| Ohtani, H | 1 |
| Miyazaki, H | 1 |
| Kurumi, M | 1 |
| Akizawa, Y | 1 |
| Oka, T | 1 |
| Ueda, Y | 1 |
| Nagasawa, K | 1 |
| Tsukamoto, H | 1 |
| Horiuchi, T | 1 |
| Yoshizawa, S | 1 |
| Tsuru, T | 1 |
| Furugo, I | 1 |
| Niho, Y | 1 |
| Suzuki, K | 1 |
| Sato, T | 1 |
| Iwaki, M | 1 |
1 trial available for gabexate and Hemolysis
| Article | Year |
|---|---|
Urinary C4 excretion in systemic lupus erythematosus.
Topics: Adolescent; Adult; Blotting, Western; Complement Activation; Complement C4; DNA; Esters; Female; Gab | 1995 |
4 other studies available for gabexate and Hemolysis
| Article | Year |
|---|---|
[Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
Topics: Abruptio Placentae; Adult; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female | 2011 |
Nafamostat mesilate, a noncalcium compound, as an anticoagulant, induces calcium-dependent haemolysis when infused with packed erythrocytes.
Topics: Anticoagulants; Benzamidines; Calcium; Citrates; Citric Acid; Drug Evaluation, Preclinical; Edetic A | 2012 |
[Inhibitory effects of sepimostat mesilate (FUT-187) on the activities of trypsin-like serine proteases in vitro].
Topics: Animals; Blood Coagulation; Esters; Gabexate; Guanidines; Guinea Pigs; Hemolysis; Humans; Imidazoles | 1995 |
[Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro].
Topics: alpha-Macroglobulins; Aprotinin; Benzamidines; Complement Inactivator Proteins; Gabexate; Glycoprote | 1986 |